Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 4/2018

01-04-2018 | Review

Are We Overtreating Renal Angiomyolipoma: A Review of the Literature and Assessment of Contemporary Management and Follow-Up Strategies

Authors: Timothy E. Murray, Michael J. Lee

Published in: CardioVascular and Interventional Radiology | Issue 4/2018

Login to get access

Abstract

Renal angiomyolipoma (AML) are benign tumours composed of fat, muscle, and disorganised blood vessels. Historic treatment algorithms for sporadic AML based on size fail to consider additional risk factors such as tumour vascularity and pseudoaneurysm formation. As AML is now predominantly incidental, rupture is rare and its mortality low. The recent publication of the largest longitudinal series to date also suggest that growth is uncommon, challenging existing surveillance paradigms. The evidence assessing treatment strategies in AML are reviewed, with particular emphasis on incidental sporadic AML. The relative merits of various AML treatments are discussed, and areas of clinical uncertainty highlighted.
Literature
1.
Soulen MC, Faykus MH Jr, Shlansky-Goldberg RD, Wein AJ, Cope C. Elective embolization for prevention of hemorrhage from renal angiomyolipomas. J Vasc Interv Radiol. 1994;5(4):587–91.PubMedCrossRef
2.
Koo KC, Kim WT, Ham WS, Lee JS, Ju HJ, Choi YD. Trends of presentation and clinical outcome of treated renal angiomyolipoma. Yonsei Med J. 2010;51(5):728–34.PubMedPubMedCentralCrossRef
3.
Hajdu SI, Foote FW Jr. Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol. 1969;102(4):396–401.PubMedCrossRef
4.
Fujii Y, Ajima J, Oka K, Tosaka A, Takehara Y. Benign renal tumors detected among healthy adults by abdominal ultrasonography. Eur Urol. 1995;27(2):124–7.PubMedCrossRef
5.
Fittschen A, Wendlik I, Oeztuerk S, Kratzer W, Akinli AS, Haenle MM. Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and out-patients. Abdom Imaging. 2014;39:1009–13.PubMedCrossRef
6.
Jinzaki M, Silverman SG, Akita H, Nagashima Y, Mikami S, Oya M. Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management. Abdom Imaging. 2014;39(3):588–604.PubMedPubMedCentralCrossRef
7.
Oesterling JE, Fishman EK, Goldman SM, Marshall FF. The management of renal angiomyolipoma. J Urol. 1986;135:1121–4.PubMedCrossRef
8.
Bhatt JR, Richard PO, Kim NS, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs > 4cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016;70(1):85–90.PubMedCrossRef
9.
Dickinson M, Ruckle H, Beaghler M, Hadley HR. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol. 1998;49:281–6.PubMed
10.
Mourikis D, Chatziioannou A, Antoniou A, Kehagias D, Gikas D, Vlahos L. Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur J Radiol. 1999;32:153–9.PubMedCrossRef
11.
12.
He W, Cheville JC, Sadow PM, et al. Epithelioid angiomyolipoma of the kidney: pathological features and clinical outcome in a series of consecutively resected tumors. Modern Pathol. 2013;26(10):1355–64.CrossRef
13.
Delhorme J-B, Fontana A, Levy A, et al. Renal angiomyolipomas: at least two diseases. A series of patients treated at two European institutions. Eur J Surg Oncol (EJSO). 2017;43(4):831–6.CrossRef
14.
Halpenny D, Snow A, McNeill G, Torreggiani WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol. 2010;65(2):99–108.PubMedCrossRef
15.
Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A. Small (< 4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology. 2012;263(1):160–8.PubMedCrossRef
16.
Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168:1315–25.PubMedCrossRef
17.
Kothary N, Soulen MC, Clark TW, Wein AJ, Shlansky-Goldberg RD, Crino PB. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol. 2005;16:45–50.PubMedCrossRef
18.
Kapoor A, Girard L, Lattouf J-B, et al. Evolving strategies in the treatment of tuberous sclerosis complex-associated angiomyolipomas (TSC-AML). Urology. 2016;89:19–26.PubMedCrossRef
19.
Murray TE, Doyle F, Lee M. Transarterial embolization of angiomyolipoma: a systematic review. J Urol. 2015;194(3):635–9.PubMedCrossRef
20.
Faddegon S, So A. Treatment of angiomyolipoma at a tertiary care centre: the decision between surgery and angioembolization. Can Urol Assoc J. 2011;5(6):E138–41.PubMedPubMedCentralCrossRef
21.
Ouzaid I, Autorino R, Fatica R, Herts BR, McLennan G, Remer EM. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int. 2014;114:412–7.PubMed
22.
Mourikis D, Chatziioannou A, Antoniou A, Kehagias D, Gikas D, Vlahos L. Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur J Radiol. 1999;32(3):153–9.PubMedCrossRef
23.
Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J. Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol. 2006;187:762–8.PubMedCrossRef
24.
Yamakado K, Tanaka N, Nakagawa T, Kobayashi S, Yanagawa M, Takeda K. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology. 2002;225:78–82.PubMedCrossRef
25.
Murray T. Transarterial embolisation of renal angiomyolipoma—a systematic review. Dublin: Royal College of Surgeons in Ireland; 2014.
26.
Champagnac J, Melodelima C, Martinelli T, et al. Microaneurysms in renal angiomyolipomas: can clinical and computed tomography features predict their presence and size? Diagn Interv Imaging. 2016;97(3):321–6.PubMedCrossRef
27.
Gandhi SP, Pal BC, Patel KN, Sutariya H, Trivedi HL. Role of 64 slice multidetector computed tomography and angiography to establish relationship between tumor size, aneurysm formation and spontaneous rupture of renal angiomyolipomas: single center experience. Urol Ann. 2016;8(2):173.PubMedPubMedCentralCrossRef
28.
Flum AS, Hamoui N, Said MA, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016;195(4):834–46.PubMedCrossRef
29.
Earthman WJ, Mazer MJ, Winfield AC. Angiomyolipomas in tuberous sclerosis: subselective embolotherapy with alcohol, with long-term follow-up study. Radiology. 1986;160(2):437–41.PubMedCrossRef
30.
Han YM, Kim JK, Roh BS, Song HY, Lee JM, Lee YH. Renal angiomyolipoma: selective arterial embolization–effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology. 1997;204:65–70.PubMedCrossRef
31.
Lee W, Kim TS, Chung JW, Han JK, Kim SH, Park JH. Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Interv Radiol. 1998;9:255–61.PubMedCrossRef
32.
Harabayashi T, Shinohara N, Katano H, Nonomura K, Shimizu T, Koyanagi T. Management of renal angiomyolipomas associated with tuberous sclerosis complex. J Urol. 2004;171(1):102–5.PubMedCrossRef
33.
Kitano Y, Honna T, Nihei K, et al. Renal angiomyolipoma in Japanese tuberous sclerosis patients. J Pediatr Surg. 2004;39(12):1784–6.PubMedCrossRef
34.
Ewalt DH, Diamond N, Rees C, Sparagana SP, Delgado M, Batchelor L. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol. 2005;174:1764–6.PubMedCrossRef
35.
Dabbeche C, Chaker M, Chemali R, et al. Role of embolization in renal angiomyolipomas. J Radiol. 2006;87(12 Pt 1):1859–67.PubMedCrossRef
36.
Rimon U, Duvdevani M, Garniek A, Golan G, Bensaid P, Ramon J. Large renal angiomyolipomas: digital subtraction angiographic grading and presentation with bleeding. Clin Radiol. 2006;61:520–6.PubMedCrossRef
37.
Rimon U, Duvdevani M, Garniek A, et al. Ethanol and polyvinyl alcohol mixture for transcatheter embolization of renal angiomyolipoma. AJR Am J Roentgenol. 2006;187(3):762–8.PubMedCrossRef
38.
Williams JM, Racadio JM, Johnson ND, Donnelly LF, Bissler JJ. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis. 2006;47(1):95–102.PubMedCrossRef
39.
Chang YH, Wang LJ, Chuang CK, Wong YC, Wu CT, Hsieh ML. The efficacy and outcomes of urgent superselective transcatheter arterial embolization of patients with ruptured renal angiomyolipomas. J Trauma. 2007;62(6):1487–90.PubMedCrossRef
40.
Lenton J, Kessel D, Watkinson AF. Embolization of renal angiomyolipoma: immediate complications and long-term outcomes. Clin Radiol. 2008;63:864–70.PubMedCrossRef
41.
Seyam RM, Bissada NK, Kattan SA, et al. Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms. Urology. 2008;72(5):1077–82.PubMedCrossRef
42.
Lee SY, Hsu HH, Chen YC, et al. Embolization of renal angiomyolipomas: short-term and long-term outcomes, complications, and tumor shrinkage. Cardiovasc Intervent Radiol. 2009;32(6):1171–8.PubMedCrossRef
43.
Ramon J, Rimon U, Garniek A, Golan G, Bensaid P, Kitrey ND. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol. 2009;55:1155–62.PubMedCrossRef
44.
Takebayashi S, Horikawa A, Arai M, Iso S, Noguchi K. Transarterial ethanol ablation for sporadic and non-hemorrhaging angiomyolipoma in the kidney. Eur J Radiol. 2009;72(1):139–45.PubMedCrossRef
45.
Bishay VL, Crino PB, Wein AJ, et al. Embolization of giant renal angiomyolipomas: technique and results. J Vasc Interv Radiol. 2010;21(1):67–72.PubMedCrossRef
46.
Chick CM, Tan BS, Cheng C, et al. Long-term follow-up of the treatment of renal angiomyolipomas after selective arterial embolization with alcohol. BJU Int. 2010;105(3):390–4.PubMedCrossRef
47.
Incedayi M, Turba UC, Arslan B, et al. Endovascular therapy for patients with renal angiomyolipoma presenting with retroperitoneal haemorrhage. Eur J Vasc Endovasc Surg. 2010;39(6):739–44.PubMedCrossRef
48.
Leong S, Keeling AN, McGrath FP, Lee MJ. Transcatheter embolisation of renal angiomyolipoma. Ir J Med Sci. 2010;179(2):211–6.PubMedCrossRef
49.
Mues AC, Palacios JM, Haramis G, Casazza C, Badani K, Gupta M. Contemporary experience in the management of angiomyolipoma. J Endourol. 2010;24:1883–6.PubMedCrossRef
50.
Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105:101–6.PubMedCrossRef
51.
Chan CK, Yu S, Yip S, Lee P. The efficacy, safety and durability of selective renal arterial embolization in treating symptomatic and asymptomatic renal angiomyolipoma. Urology. 2011;77(3):642–8.PubMedCrossRef
52.
Planche O, Correas JM, Mader B, Joly D, Mejean A, Helenon O. Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. J Vasc Interv Radiol. 2011;22(10):1388–95.PubMedCrossRef
53.
Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol. 2011;186(3):921–7.PubMedCrossRef
54.
Chatziioannou A, Gargas D, Malagari K, et al. Transcatheter arterial embolization as therapy of renal angiomyolipomas: the evolution in 15 years of experience. Eur J Radiol. 2012;81(9):2308–12.PubMedCrossRef
55.
Patatas K, Robinson GJ, Ettles DF, Lakshminarayan R. Patterns of renal angiomyolipoma regression post embolisation on medium- to long-term follow-up. Br J Radiol. 1024;2013(86):20120633.
56.
Koh KB, George J. Radiological parameters of bleeding renal angiomyolipoma. Scand J Urol Nephrol. 1996;30:265–8.PubMedCrossRef
57.
De Luca S, Terrone C, Rossetti SR. Management of renal angiomyolipoma: a report of 53 cases. BJU Int. 1999;83(3):215–8.PubMedCrossRef
58.
Yip S, Tan P, Cheng W, Li M, Foo K. Surgical management of angiomyolipoma: nephron-sparing surgery for symptomatic tumour. Scand J Urol Nephrol. 2000;34(1):32–5.PubMedCrossRef
59.
Tsai HN, Chou YH, Shen JT, et al. The management strategy of renal angiomyolipoma. Kaohsiung J Med Sci. 2002;18(7):340–6.PubMed
60.
Eijkemans MJC, van der Wal W, Reijnders LJ, et al. Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in The Netherlands. Am J Kidney Dis. 2015;66(4):638–45.PubMedCrossRef
61.
Amin S, Lux A, Calder N, Laugharne M, Osborne J. O’callaghan F. Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 2017;59(6):612–7.PubMedCrossRef
62.
Urbano J, Paul L, Cabrera M, Alonso-Burgos A, Gómez D. Elective and emergency renal angiomyolipoma embolization with ethylene vinyl alcohol copolymer: feasibility and initial experience. J Vasc Interv Radiol. 2017;28(6):832–9.PubMedCrossRef
63.
Wang C, Yang M, Tong X, et al. Transarterial embolization for renal angiomyolipomas: a single centre experience in 79 patients. J Int Med Res. 2017;45(2):706–13.PubMedPubMedCentralCrossRef
64.
Pode D, Meretik S, Shapiro A, Caine M. Diagnosis and management of renal angiomyolipoma. Urology. 1985;25(5):461–7.PubMedCrossRef
65.
Zhang JQ, Fielding JR, Zou KH. Etiology of spontaneous perirenal hemorrhage: a meta-analysis. J Urol. 2002;167(4):1593–6.PubMedCrossRef
66.
Zurera TL, Delgado AF, Ysamat MR, Pareja AM, Alegre BN, Requena M. Retroperitoneal hemorrhage as a complication of renal angiomyolipoma. Arch Esp Urol. 1989;43(1):27–31.
67.
Triantopoulou PACDC, Costacopoulos DPCDA. Complications of renal angiomyolipomas: CT evaluation. Abdom Imaging. 1996;21(4):357–60.PubMedCrossRef
68.
Lu C-Y, Min P-Q, Wu B. CT evaluation of spontaneously ruptured renal angiomyolipomas with massive hemorrhage spreading into multi-retroperitoneal fascia and fascial spaces. Acta Radiol Short Rep. 2012;1(4):arsr.2012.110009.PubMedPubMedCentral
69.
Bechtold RE, Dyer RB, Zagoria RJ, Chen M. The perirenal space: relationship of pathologic processes to normal retroperitoneal anatomy. Radiographics. 1996;16(4):841–54.PubMedCrossRef
70.
Heller MT, Haarer KA, Thomas E, Thaete FL. Acute conditions affecting the perinephric space: imaging anatomy, pathways of disease spread, and differential diagnosis. Emerg Radiol. 2012;19(3):245–54.PubMedCrossRef
71.
Gawenda M, Brunkwall J. Ruptured abdominal aortic aneurysm: the state of play. Deutsch Ärztebl Int. 2012;109(43):727–32.
72.
Raft J, Lalot J, Meistelman C, Longrois D. Influence of pregnancy on renal angiomyolipoma. Gynecol Obstet Fertil. 2005;33(11):898–906.PubMedCrossRef
73.
Zapardiel I, Delafuente-Valero J, Bajo-Arenas JM. Renal angiomyolipoma during pregnancy: review of the literature. Gynecol Obstet Invest. 2011;72(4):217–9.PubMedCrossRef
74.
Colussi G, Surian M, Corradi B, et al. Renal failure caused by renal angiomyolipoma. 2 Cases of which one is a pregnancy at term. Minerva Nefrol. 1979;27(2):359–64.
75.
Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2013;381(9869):817–24.PubMedCrossRef
76.
Krueger DA, Northrup H. Group ITSCC. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013;49(4):255–65.PubMedPubMedCentralCrossRef
77.
78.
Hocquelet A, Cornelis F, Le Bras Y, et al. Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol. 2014;24(8):1785–93.PubMedCrossRef
79.
Muller A, Rouvière O. Renal artery embolization [mdash] indications, technical approaches and outcomes. Nat Rev Nephrol. 2015;11(5):288–301.PubMedCrossRef
80.
Thulasidasan N, Sriskandakumar S, Ilyas S, Sabharwal T. Renal angiomyolipoma: mid- to long-term results following embolization with onyx. Cardiovasc Intervent Radiol. 2016;39(12):1759–64.PubMedCrossRef
81.
Huyghe E, Dechier MC, Mottier ML, et al. 1365 Management of renal angiomyolipoma: medical and cost effectiveness comparison of selective embolization and surgery. J Urol. 2010;183(4):e527.CrossRef
82.
Kiefer RM, Stavropoulos SW. The role of interventional radiology techniques in the management of renal angiomyolipomas. Curr Urol Rep. 2017;18(5):36.PubMedCrossRef
83.
Castle SM, Gorbatiy V, Ekwenna O, Young E, Leveillee RJ. Radiofrequency ablation (RFA) therapy for renal angiomyolipoma (AML): an alternative to angio-embolization and nephron-sparing surgery. BJU Int. 2012;109:384–7.PubMedCrossRef
84.
Guan W, Bai J, Liu J, et al. Microwave ablation versus partial nephrectomy for small renal tumors: intermediate-term results. J Surg Oncol. 2012;106(3):316–21.PubMedCrossRef
85.
Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter TC III, Lee FT Jr. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. Am J Roentgenol. 2008;191(4):1159–68.CrossRef
86.
Laviana AA, Kundavaram CR, Tan H-J, et al. Determining the true costs of treating small renal masses using time driven, activity based costing. Urol Pract. 2016;3(3):180–6.CrossRef
87.
Golan S, Johnson SC, Maurice MJ, et al. Safety and early effectiveness of robot-assisted partial nephrectomy for large angiomyolipomas. BJU Int. 2017;119(5):755–60.PubMedCrossRef
88.
Boorjian SA, Frank I, Inman B, Lohse CM, Cheville JC, Leibovich BC. The role of partial nephrectomy for the management of sporadic renal angiomyolipoma. Urology. 2007;70:1064–8.PubMedCrossRef
89.
Nazemi T, Galich A, Sterrett S, Klingler D, Smith L, Balaji K. Radical nephrectomy performed by open, laparoscopy with or without hand-assistance or robotic methods by the same surgeon produces comparable perioperative results. Int Braz J Urol. 2006;32(1):15–22.PubMedCrossRef
90.
Mir SA, Cadeddu JA, Sleeper JP, Lotan Y. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol. 2011;25(3):447–53.PubMedCrossRef
91.
Tan K, Huang SK-H, Lee KH, Lai W-H. Comparison of large renal angiomyolipoma with or without transcatheter arterial embolization before partial nephrectomy. Urol Sci. 2016;27(2):S46.CrossRef
Metadata
Title
Are We Overtreating Renal Angiomyolipoma: A Review of the Literature and Assessment of Contemporary Management and Follow-Up Strategies
Authors
Timothy E. Murray
Michael J. Lee
Publication date
01-04-2018
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 4/2018
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1862-3

Other articles of this Issue 4/2018

CardioVascular and Interventional Radiology 4/2018 Go to the issue

Letter to the Editor

Reply to Letter

Clinical Investigation

Early Experience and Lessons Learnt with Customized Fenestrated Thoracic Endovascular Aortic Reconstruction for Aortic Arch Pathology in an Asian Population

Clinical Investigation

Trans-Urethral Ureteral Stent Replacement Technique (TRUST): 10-Year Experience in 1168 Patients

Clinical Investigation

Denali, Tulip, and Option Inferior Vena Cava Filter Retrieval: A Single Center Experience

Clinical Investigation

Long Parallel Stent Grafts for the Treatment of Complex Aortic Aneurysms

Letter to the Editor

Immediate Resolution of a Grade 3 Varicocele Post-Prostatic Artery Embolisation (PAE)